KPTI
Karyopharm Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.85
-0.05 ▼ -0.63%
🌙 3월 13일 7:41 PM ET (한국 3/14 08:41)
$7.79
-0.06 ▼ -0.76%
| Index | - | P/E | - | EPS (ttm) | -16.62 | Insider Own | 7.38% | Shs Outstand | 0.02B | Perf Week | -10.49% |
| Market Cap | 0.14B | Forward P/E | - | EPS next Y | 40.82% | Insider Trans | -1.9% | Shs Float | 0.02B | Perf Month | 6.51% |
| Enterprise Value | 0.31B | PEG | - | EPS next Q | -1.3 | Inst Own | 62.1% | Short Float | 17.49% | Perf Quarter | 21.14% |
| Income | -0.20B | P/S | 0.99 | EPS this Y | 73.09% | Inst Trans | 33.39% | Short Ratio | 5.51 | Perf Half Y | 18.22% |
| Sales | 0.15B | P/B | - | EPS next 5Y | - | ROA | -139.1% | Short Interest | 2.97M | Perf YTD | 6.66% |
| Book/sh | -16 | P/C | 2.26 | EPS past 3/5Y | 16.03% 15.19% | ROE | - | 52W High | -28.57% ($10.99) | Perf Year | 13.11% |
| Cash/sh | 3.47 | P/FCF | - | Sales past 3/5Y | -2.39% 6.21% | ROIC | - | 52W Low | 123.65% ($3.51) | Perf 3Y | -84.92% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -76.41% | Gross Margin | 95.72% | Volatility(W/M) | 11.71% 11.5% | Perf 5Y | -95.75% |
| Dividend TTM | - | EV/Sales | 2.15 | Sales Y/Y TTM | 0.57% | Oper. Margin | -62.1% | ATR (14) | 0.82 | Perf 10Y | -93.38% |
| Dividend Ex-Date | - | Quick Ratio | 1.08 | EPS Q/Q | -55.63% | Profit Margin | -134.21% | RSI (14) | 42.95 | Recom | 1.38 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.12 | Sales Q/Q | 11.58% | SMA20 | -13.83% ($9.11) | Beta | 0.25 | Target Price | $17.14 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | 0.01% ($7.85) | Rel Volume | 1.29 | Prev Close | $7.9 |
| Employees | 228 | LT Debt/Eq | - | EPS/Sales Surpr. | -186.32% -2.92% | SMA200 | 28.51% ($6.11) | Avg Volume(3M) | 0.54M | Price | $7.85 |
| IPO | 2013/11/6 | Option/Short | Yes/Yes | Trades | 3612 | Volume | 696,861 | Change | -0.63% |
뉴스 로딩 중...